Everstone Scores Big Return As It Sells Controlling Stake In India’s Rubicon Research

Everstone Group has signed a deal to sell its controlling stake in Indian contract research firm Rubicon Research to General Atlantic for a reported INR10bn ($145mn), generating a more than four-time return on its initial investment.

Notes
Everstone Will Sell Its Stake In Rubicon For A Reported INR10bn • Source: Shutterstock

The Everstone Group is selling its controlling stake in Rubicon Research to a global private-equity player for an estimated INR10bn ($145.12mn), more than quadrupling its return on the investment it made in the Mumbai-based contract research and manufacturing services (CRAMS) company three years ago.

Everstone, a Singapore-based private-equity firm, did not identify the buyer but Indian media named the purchaser as General Atlantic, a...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business